OrthoPediatrics Corp. (KIDS) is making waves in the pediatric healthcare landscape with the launch of its new Enabling Technologies division. This strategic move, led by industry veteran Kevin Unger, marks a significant step forward in OrthoPediatrics’ commitment to addressing unmet needs in pediatric orthopedics.
This new division is set to propel OrthoPediatrics to the forefront of the rapidly growing pediatric digital health sector, generating sustainable revenue growth and unlocking opportunities in new markets beyond traditional orthopedics.
The foundation for this division rests upon OrthoPediatrics’ impressive track record of innovation in the field. The company has already made significant strides with the distribution of the 7D Flash Navigation System, a cutting-edge tool for surgical guidance. Additionally, OrthoPediatrics has collaborated with 3D Side, S.A. to develop patient-specific cutting guides, further enhancing precision and personalized treatment.
Building upon these successes, OrthoPediatrics is launching two groundbreaking technology platforms that will revolutionize pediatric healthcare:
*
Playbook:
This innovative surgical workflow and outcome optimization platform is designed to enhance surgical planning, collaboration, and intraoperative workflow. Playbook has the potential to dramatically improve surgical outcomes and efficiency, transforming the way surgeries are planned and executed.*
Robotic-Assistance for Cochlear Implant Technology:
OrthoPediatrics has partnered with iotaMotion, Inc. to bring a robotic-assisted insertion system to the market. This technology offers a slower, more controlled insertion of the electrode array during cochlear implant surgery, regardless of the implant manufacturer. This enhanced precision and control will benefit pediatric patients significantly.These advancements are not isolated events. In May, OrthoPediatrics received Breakthrough Device designation from the Food and Drug Administration for its new eLLi surgical device. This implant is designed to treat severe pathology associated with early onset scoliosis, a potentially life-threatening condition.
Earlier this year, the company launched the RESPONSE Rib and Pelvic Fixation system, a first-of-its-kind solution for children at risk of thoracic insufficiency syndrome. This system features implants, instruments, and devices for rib and pelvic fixation, providing comprehensive treatment options for these complex cases.
The timing of OrthoPediatrics’ latest announcements couldn’t be better. According to Grand View Research, the global pediatric orthopedic devices market is expected to grow significantly, reaching a value of $3.83 billion by 2023 and experiencing a CAGR of 11.0% from 2024 to 2030. This growth is driven by several factors, including increased awareness of orthopedic conditions in children, the rise in congenital and developmental disorders, and the development of innovative, adjustable, and customizable devices.
While shares of KIDS have risen 0.7% year to date, the company is well-positioned to capitalize on the growth potential of the pediatric digital health market. The company’s focus on developing solutions that address specific needs in pediatric orthopedics, coupled with its commitment to innovation, positions OrthoPediatrics for continued success.
